Consumer

Discussion in 'GlaxoSmithKline' started by Anonymous, Mar 26, 2015 at 7:33 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    What's going on? 1/2 the team being given packages the other 1/2 quitting. Excellent plan.
     

  2. Anonymous

    Anonymous Guest

    What is going on? Let us in on what is happening there?
     
  3. Anonymous

    Anonymous Guest

    us? who's us?
     
  4. Anonymous

    Anonymous Guest

    extra focus on leadership and AW has hand picked players he needs with promotions. Many more leaving shortly. Category structure not managed for success.
     
  5. Anonymous

    Anonymous Guest

    sunk
     
  6. Anonymous

    Anonymous Guest

    GSK formula FUBR
     
  7. Anonymous

    Anonymous Guest

    Singapore a total waste of time
     
  8. Anonymous

    Anonymous Guest

    every decision is short term focused. Locations, appointments. Expect GSK to fail in Consumer like they have in Pharma.
     
  9. Anonymous

    Anonymous Guest

    shocking appointments more will resign
     
  10. Anonymous

    Anonymous Guest

    At least management is getting rid of the Novartis R&D baggage in Nebraska. What a sad bunch of egotistical and complacent incompetents.

    People have been told to keep quiet about their actual dates, but it's happening....

    Oh happy day.
     
  11. Anonymous

    Anonymous Guest

    good news if they do the same with supply chain you'd have no one left but you would still be better off.
     
  12. Anonymous

    Anonymous Guest

    R&D changes will delay & deteriorate pipeline. Not positioned to win!
     
  13. Anonymous

    Anonymous Guest

    Sounds as if there are some very smart businessmen here.......get their cell numbers Mr. Trump !
     
  14. Anonymous

    Anonymous Guest

    I have gas